Sign in

CIK 0001840706

  • Accelerated filer
  • Emerging growth company

SOPHiA GENETICS SA

Sign in to watch
Ticker
SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 216941060
Business address
LA PIECE, CH-1180, ROLLE, Switzerland, 00000
  1. 4 Planned sale Chief Executive Officer sold 8,500 shares at $5.09 ($43,241)
  2. 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.82 ($24,089)
  3. 4 Planned sale Chief People Officer sold 380 shares at $5.20 ($1,977)
  4. 4 Planned sale Chief Scientific Officer sold 608 shares at $5.21 ($3,165)
  5. 4 Planned sale Chief Legal Officer sold 684 shares at $5.20 ($3,554)
  6. 4 Planned sale Chief Executive Officer sold 4,486 shares at $5.21 ($23,350)
  7. 4 Planned sale Chief Medical Officer sold 608 shares at $5.20 ($3,162)
  8. 4 Planned sale President sold 760 shares at $5.20 ($3,955)
  9. 4 Open-market sale Chief Sales Officer sold 33 shares at $5.08 ($168)
  10. 4 Planned sale Chief Scientific Officer sold 600 shares at $4.97 ($2,980)
  11. 4 Planned sale Chief Executive Officer sold 60,602 shares at an average $4.97 ($301,235)
  12. 4 Planned sale Chief Medical Officer sold 1,600 shares at $4.96 ($7,933)
  13. 4 Planned sale President sold 2,800 shares at $4.96 ($13,887)
  14. 4 Planned sale Chief Legal Officer sold 2,400 shares at $4.67 ($11,201)
  15. 4 Planned sale Chief Scientific Officer sold 8,120 shares at an average $4.73 ($38,374)
  16. 4 Planned sale Chief Executive Officer sold 16,631 shares at an average $4.73 ($78,668)
  17. 4 Planned sale President sold 8,129 shares at an average $4.73 ($38,445)
  18. 4 Planned sale Chief Medical Officer sold 8,125 shares at an average $4.73 ($38,404)
  19. 4 Planned sale Chief Executive Officer sold 4,750 shares at an average $4.80 ($22,797)
  20. 4 Planned sale President sold 4,736 shares at an average $4.80 ($22,727)

Page 5 of 8 · 156 filings